Acknowledgement
이 논문은 2021년도 동덕여자대학교 연구비 지원에 의하여 수행된 것으로 이에 감사드립니다.
References
- Burch RC, Loder S, Loder E, Smitherman TA. The prevalence and burden of migraine and severe headache in the United States: Updated statistics from government health surveillance studies. Headache 2015;55(1):21-34. https://doi.org/10.1111/head.12482
- Smitherman TA, Burch R, Sheikh H, Loder E. The prevalence, impact, and treatment of migraine and severe headaches in the United States: A review of statistics from national surveillance studies. Headache 2013;53(3):427-36. https://doi.org/10.1111/head.12074
- Ashina M. Migraine. N Engl J Med 2020;383(19):1866-76. https://doi.org/10.1056/NEJMra1915327
- Mortimer MJ, Kay J, Jaron A. Epidemiology of headache and childhood migraine in an urban general practice using Ad Hoc, Vahlquist and IHS criteria. Dev Med Child Neurol 1992;34(12):1095-101. https://doi.org/10.1111/j.1469-8749.1992.tb11423.x
- GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2018;17(11):954-76. https://doi.org/10.1016/S1474-4422(18)30322-3
- Rho YI, Chung HJ, Lee KH, et al. Prevalence and clinical characteristics of primary headaches among school children in South Korea: a nationwide survey. Headache 2012;52(4):592-9. https://doi.org/10.1111/j.1526-4610.2011.02001.x
- Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventative therapy. Neurology 2007;68(5):343-9. https://doi.org/10.1212/01.wnl.0000252808.97649.21
- Deubner DC. An epidemiologic study of migraine and headache in 10-20 year olds. Headache 1977;17(4):173-80. https://doi.org/10.1111/j.1526-4610.1977.hed1704173.x
- Lee LH, Olness KN. Clinical and demographic characteristics of migraine in urban children. Headache 1997;37(5):269-76. https://doi.org/10.1046/j.1526-4610.1997.3705269.x
- KH Lee. Recent updates on treatment for pediatric migraine. J Korean Med Assoc 2017:60(2):118-25. https://doi.org/10.5124/jkma.2017.60.2.118
- Eun SH, Eun BL. Headaches in children and adolescents: diagnosis and treatment. Korean J Pediatr 2006:49(4);354-63. https://doi.org/10.3345/kjp.2006.49.4.354
- Patniyot I, Qubty W. Short-term treatment of migraine in children and adolescents. JAMA Pediatr 2020;174(8):789-90. https://doi.org/10.1001/jamapediatrics.2020.1422
- Oskoui M, Pringsheim T, Holler-Managan Y, et al. Practice guideline update summary: Acute treatment of migraine in children and adolescents: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology 2019;93(11):487-99. https://doi.org/10.1212/WNL.0000000000008095
- Thorlund K, Sun-Edelstein C, Druyts E, et al. Risk of medication overuse headache across classes of treatments for acute migraine. J Headache Pain. 2016;17(1):107. https://doi.org/10.1186/s10194-016-0696-8
- Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study. Headache 2008;48(8):1157-68. https://doi.org/10.1111/j.1526-4610.2008.01217.x
- El-Chammas K, Keyes J, Thompson N, Vijayakumar J, Becher D, Jackson JL. Pharmacologic treatment of pediatric headaches: a meta-analysis. JAMA Pediatr 2013;167(3):250-8. https://doi.org/10.1001/jamapediatrics.2013.508
- O'Brien HL, Kabbouche MA, Hershey AD. Treating pediatric migraine: an expert opinion. Expert Opin Pharmacother 2012;13(7):959-66. https://doi.org/10.1517/14656566.2012.677434
- Shamliyan TA, Kane RL, Ramakrishnan R, Taylor FR. Episodic migraines in children: limited evidence on preventive pharmacological treatments. J Child Neurol 2013;28(10):1320-41. https://doi.org/10.1177/0883073813488659
- Hershey AD, Powers SW, Bentti AL, Degrauw TJ. Effectiveness of amitriptyline in the prophylactic management of childhood headaches. Headache 2000;40(7):539-49. https://doi.org/10.1046/j.1526-4610.2000.00085.x
- Kim J, Lee S, Rhew K. Association between Gastrointestinal Diseases and Migraine. Int J Environ Res Public Health 2022;19(7):4018. https://doi.org/10.3390/ijerph19074018
- Ho TW, Pearlman E, Lewis D, et al. Efficacy and tolerability of rizatriptan in pediatric migraineurs: results from a randomized, double-blind, placebo-controlled trial using a novel adaptive enrichment design. Cephalalgia 2012;32(10):750-65. https://doi.org/10.1177/0333102412451358
- Lewis DW, Winner P, Hershey AD, Wasiewski WW; Adolescent Migraine Steering Committee. Efficacy of zolmitriptan nasal spray in adolescent migraine. Pediatrics 2007;120(2):390-6. https://doi.org/10.1542/peds.2007-0085
- Lewis DW, Winner P. The pharmacological treatment options for pediatric migraine: An evidence-based appraisal. NeuroRx 2006;3(2):181-91. https://doi.org/10.1016/j.nurx.2006.01.002
- Genizi J, Lahoud D, Cohen R. Migraine abortive treatment in children and adolescents in Israel. Sci Rep 2022;12(1):7418. https://doi.org/10.1038/s41598-022-11467-3
- Damen L, Bruijn JK, Verhagen AP, Berger MY, Passchier J, Koes BW. Symptomatic treatment of migraine in children: A systematic review of medication trials. Pediatrics 2005;116(2):e295-302. https://doi.org/10.1542/peds.2004-2742
- Richer L, Billinghurst L, Linsdell MA, et al. Drugs for the acute treatment of migraine in children and adolescents. Cochrane Database Syst Rev 2016;4(4):CD005220.
- Ludvigsson J. Propranolol used in prophylaxis of migraine in children. Acta Neurol Scand 1974;50(1):109-15. https://doi.org/10.1111/j.1600-0404.1974.tb01350.x
- Sorge F, De Simone R, Marano E, Nolano M, Orefice G, Carrieri P. Flunarizine in prophylaxis of childhood migraine. A double-blind, placebo-controlled, crossover study. Cephalalgia 1988;8(1):1-6. https://doi.org/10.1046/j.1468-2982.1988.0801001.x
- Forsythe WI, Gillies D, Sills MA. Propanolol ('Inderal') in the treatment of childhood migraine. Dev Med Child Neurol 1984;26(6):737-41. https://doi.org/10.1111/j.1469-8749.1984.tb08166.x
- Powers SW, Coffey CS, Chamberlin LA, Ecklund DJ, Klingner EA, Yankey JW, et al. Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine. N Engl J Med 2017;376(2):115-24 https://doi.org/10.1056/NEJMoa1610384
- Lewis D, Winner P, Saper J, Ness S, Polverejan E, Wang S, et al. Randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of topiramate for migraine prevention in pediatric subjects 12 to 17 years of age. Pediatrics 2009;123(3):924-34. https://doi.org/10.1542/peds.2008-0642
- Winner P, Pearlman EM, Linder SL, Jordan DM, Fisher AC, Hulihan J. Topiramate for migraine prevention in children: a randomized, double-blind, placebo-controlled trial. Headache 2005;45(10):1304-12. https://doi.org/10.1111/j.1526-4610.2005.00262.x